I think it is a certainty that Neuren will get into the asx 300.The stock is extremely tightly held and the only seller seems to be lanstead .With the increase in price they will have to be putting in about $900,000 per month until December 2018 .The deal Dt T did on Lanstead was extremely good.They committed to $10 mill but will be putting in $20 million plus .They have done very well as well .
- Forums
- ASX - By Stock
- NEU
- S&P Rebalance
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.40%
!
$17.09
S&P Rebalance, page-4
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
